Homoazanicotine: A structure-affinity study for nicotinic acetylcholine (nACh) receptor binding

被引:14
作者
Ferretti, G
Dukat, M
Giannella, M
Piergentili, A
Pigini, M
Quaglia, W
Damaj, MI
Martin, BR
Glennon, RA
机构
[1] Univ Camerino, Dipartimento Sci Chim, I-6032 Camerino, Italy
[2] Virginia Commonwealth Univ, Sch Pharm, Dept Med Chem, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
D O I
10.1021/jm020188s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have recently identified 3-[(1-methyl)-4,5-dihydro-1H-imidazol-2-yl)methyl]pyridine (homo-azanicotine, 8) as a novel nicotinic acetylcholinergic (nACh) receptor ligand. In the present investigation, after we determined that 8 binds selectively at nicotinic (K-i = 7.8 nM) vs muscarinic (K-i > 10 000 nM) acetylcholinergic receptors, we examined its structure-affinity relationships for nACh receptor binding. The features investigated included the influence of (i) the composition of connector that separates the two rings, (ii) the N-methyl group, (iii) the ring opening of the imidazoline ring, (iv) the pyridine nitrogen atom, and (v) the aromatization of the imidazoline ring on nACh receptor affinity. As with nicotine, the parent structure seems optimal and most structural changes reduce nACh receptor affinity. Also, as with nicotine analogues, alteration of the spacer group influences affinity in a manner that is somewhat different than that seen with the parent structure.
引用
收藏
页码:4724 / 4731
页数:8
相关论文
共 37 条
  • [1] Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
    Abreo, MA
    Lin, NH
    Garvey, DS
    Gunn, DE
    Hettinger, AM
    Wasicak, JT
    Pavlik, PA
    Martin, YC
    DonnellyRoberts, DL
    Anderson, DJ
    Sullivan, JP
    Williams, M
    Americ, SP
    Holladay, MW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) : 817 - 825
  • [2] SYNTHESIS AND REACTIONS OF HETEROCYCLIC 2,3-EPOXYPROPIONITRILES WITH PYRROLIDINE
    AGARWAL, KC
    KNAUS, EE
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 1987, 24 (01) : 15 - 17
  • [3] [Anonymous], NEURONAL NICOTINIC R
  • [4] ARNERIC SP, 1999, NEURONAL NICOTINIC F
  • [5] Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase
    Augeri, DJ
    O'Connor, SJ
    Janowick, D
    Szczepankiewicz, B
    Sullivan, G
    Larsen, J
    Kalvin, D
    Cohen, J
    Devine, E
    Zhang, HC
    Cherian, S
    Saeed, B
    Ng, SC
    Rosenberg, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (22) : 4288 - 4300
  • [6] STRUCTURE AND ACTIVITY OF ACETYLCHOLINE
    BEERS, WH
    REICH, E
    [J]. NATURE, 1970, 228 (5275) : 917 - &
  • [7] CALDWELL WS, 1998, Patent No. 5248690
  • [8] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [9] Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors
    Cheng, YX
    Dukat, M
    Dowd, M
    Fiedler, W
    Martin, B
    Damaj, MI
    Glennon, RA
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (02) : 177 - 190
  • [10] Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284